Depending on environmental cues, cells use different sumoylation sites and SUMO isoforms to finetune the activity of the PPARγ complex, resulting either in its activation or inhibition; however, we believe that during normal AD the overall effect of sumoylation on PPARγ/RXR is to activate the complex. The gene discussed is PPARG; the disease is Alzheimer disease.